Extended half-life factor VIII for immune tolerance induction in haemophilia-Reference-Cited by-同舟云学术

Extended half-life factor VIII for immune tolerance induction in haemophilia

Published:2016-09-19 Issue:6 Volume:22 Page:e552-e554
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Malec L. M.¹²,Journeycake J.³⁴,Ragni M. V.¹²

Affiliation:

1. University of Pittsburgh School of Medicine; Pittsburgh PA USA

2. Hemophilia Center of Western Pennsylvania; Pittsburgh PA USA

3. University of Texas Southwestern School of Medicine; Dallas TX USA

4. Bleeding Disorder and Thrombosis; Program Pauline Allen Gill Center for Cancer and Blood Disorders; Dallas TX USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13064/fullpdf

Reference10 articles.

1. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

2. Guidelines for the management of hemophilia (2nd Edition);World Federation of Hemophilia;Haemophilia,2013

3. Safety and prolonged activity of recombinant factor FVIII Fc fusion protein in hemophilia A patients;Powell;Blood,2012

4. Phase 3 study of recombinant factor VIIIFc fusion protein in severe hemophilia A;Mahlangu;Blood,2014

5. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A;Collins;JTH,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?;Journal of Thrombosis and Haemostasis;2023-11

2. No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients;Haemophilia;2023-06-05

3. Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study;Blood;2023-04-20

4. Management of haemophilia A with inhibitors: A regional cross‐talk;Haemophilia;2022-07-22

5. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy;International Journal of Hematology;2022-05-03